Join
Live feed
·
INSIDERFilingvia Quantisnow
Fennec Pharmaceuticals Inc. logo

Former Director Raykov Rosty sold $95,800 worth of shares (10,000 units at $9.58) as part of a pre-agreed trading plan, decreasing direct ownership by 7% to 131,633 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
FENC· Fennec Pharmaceuticals Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FENC (Fennec Pharmaceuticals Inc.) and more on Quantisnow.